These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 23345947

  • 1. Atorvastatin and rosuvastatin do not prevent thioacetamide induced liver cirrhosis in rats.
    Shirin H, Sharvit E, Aeed H, Gavish D, Bruck R.
    World J Gastroenterol; 2013 Jan 14; 19(2):241-8. PubMed ID: 23345947
    [Abstract] [Full Text] [Related]

  • 2. NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin.
    Satoh M, Tabuchi T, Itoh T, Nakamura M.
    Clin Sci (Lond); 2014 Feb 14; 126(3):233-41. PubMed ID: 23944632
    [Abstract] [Full Text] [Related]

  • 3. Effects of rosuvastatin and atorvastatin on the apolipoprotein B/apolipoprotein A-1 ratio in patients with an acute coronary syndrome: The CENTAURUS trial design.
    Lablanche JM, Danchin N, Farnier M, Tedgui A, Vicaut E, Alonso J, Crean P, Leone A, Morais J, Santini M, Licour M, Farah M, Tardif JC.
    Arch Cardiovasc Dis; 2008 Jun 14; 101(6):399-406. PubMed ID: 18809153
    [Abstract] [Full Text] [Related]

  • 4. Is rosuvastatin really a more efficient therapeutic option than atorvastatin?
    Soto J, Fernandez de Bobadilla J.
    Value Health; 2006 Jun 14; 9(4):276-7; author reply 277-9. PubMed ID: 16903999
    [No Abstract] [Full Text] [Related]

  • 5. Lipidomic approach to evaluate rosuvastatin and atorvastatin at various dosages: investigating differential effects among statins.
    Bergheanu SC, Reijmers T, Zwinderman AH, Bobeldijk I, Ramaker R, Liem AH, van der Greef J, Hankemeier T, Jukema JW.
    Curr Med Res Opin; 2008 Sep 14; 24(9):2477-87. PubMed ID: 18655752
    [Abstract] [Full Text] [Related]

  • 6. Rosuvastatin, pravastatin, and atorvastatin for the treatment of hypercholesterolaemia in HIV-infected patients receiving protease inhibitors.
    Calza L, Manfredi R, Colangeli V, Pocaterra D, Pavoni M, Chiodo F.
    Curr HIV Res; 2008 Nov 14; 6(6):572-8. PubMed ID: 18991624
    [Abstract] [Full Text] [Related]

  • 7. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE, Feely J, Sigurdsson EL, DISCOVERY study group.
    Clin Ther; 2004 Nov 14; 26(11):1821-33. PubMed ID: 15639694
    [Abstract] [Full Text] [Related]

  • 8. Oxidative stress and inflammation are differentially affected by atorvastatin, pravastatin, rosuvastatin, and simvastatin on lungs from mice exposed to cigarette smoke.
    Ferreira TS, Lanzetti M, Barroso MV, Rueff-Barroso CR, Benjamim CF, de Brito-Gitirana L, Porto LC, Valença SS.
    Inflammation; 2014 Oct 14; 37(5):1355-65. PubMed ID: 24609836
    [Abstract] [Full Text] [Related]

  • 9. Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trial.
    de Zeeuw D, Anzalone DA, Cain VA, Cressman MD, Heerspink HJ, Molitoris BA, Monyak JT, Parving HH, Remuzzi G, Sowers JR, Vidt DG.
    Lancet Diabetes Endocrinol; 2015 Mar 14; 3(3):181-90. PubMed ID: 25660356
    [Abstract] [Full Text] [Related]

  • 10. Comparative Effectiveness and Toxicity of Statins Among HIV-Infected Patients.
    Singh S, Willig JH, Mugavero MJ, Crane PK, Harrington RD, Knopp RH, Kosel BW, Saag MS, Kitahata MM, Crane HM.
    Clin Infect Dis; 2011 Feb 01; 52(3):387-95. PubMed ID: 21189273
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness of rosuvastatin versus atorvastatin in reducing lipid levels and achieving low-density-lipoprotein cholesterol goals in a usual care setting.
    Bullano MF, Kamat S, Wertz DA, Borok GM, Gandhi SK, McDonough KL, Willey VJ.
    Am J Health Syst Pharm; 2007 Feb 01; 64(3):276-84. PubMed ID: 17244877
    [Abstract] [Full Text] [Related]

  • 12. Pharmacodynamic effects of atorvastatin versus rosuvastatin in coronary artery disease patients with normal platelet reactivity while on dual antiplatelet therapy--the PEARL randomized cross-over study.
    Pelliccia F, Rosano G, Marazzi G, Vitale C, Spoletini I, Franzoni F, Speziale G, Polacco M, Greco C, Gaudio C.
    Eur J Pharmacol; 2014 Feb 15; 725():18-22. PubMed ID: 24444439
    [Abstract] [Full Text] [Related]

  • 13. Comparison of effects of rosuvastatin and atorvastatin on plaque regression in Korean patients with untreated intermediate coronary stenosis.
    Hong YJ, Jeong MH, Hachinohe D, Ahmed K, Choi YH, Cho SH, Hwang SH, Ko JS, Lee MG, Park KH, Sim DS, Yoon NS, Yoon HJ, Kim KH, Park HW, Kim JH, Ahn Y, Cho JG, Park JC, Kang JC.
    Circ J; 2011 Feb 15; 75(2):398-406. PubMed ID: 21157106
    [Abstract] [Full Text] [Related]

  • 14. Dabigatran Reduces Liver Fibrosis in Thioacetamide-Injured Rats.
    Lee KC, Hsu WF, Hsieh YC, Chan CC, Yang YY, Huang YH, Hou MC, Lin HC.
    Dig Dis Sci; 2019 Jan 15; 64(1):102-112. PubMed ID: 30288660
    [Abstract] [Full Text] [Related]

  • 15. The DISCOVERY PENTA study: a DIrect Statin COmparison of LDL-C Value--an Evaluation of Rosuvastatin therapY compared with atorvastatin.
    Fonseca FA, Ruiz A, Cardona-Muñoz EG, Silva JM, Fuenmayor N, Marotti M, DISCOVERY PENTA investigators.
    Curr Med Res Opin; 2005 Aug 15; 21(8):1307-15. PubMed ID: 16083541
    [Abstract] [Full Text] [Related]

  • 16. Effects of rosuvastatin and atorvastatin on glycaemic control in Type 2 diabetes---the CORALL study.
    Simsek S, Schalkwijk CG, Wolffenbuttel BH.
    Diabet Med; 2012 May 15; 29(5):628-31. PubMed ID: 22151023
    [Abstract] [Full Text] [Related]

  • 17. Effects of rosuvastatin versus atorvastatin on rho-associated coiled-coil containing protein kinase activity and endothelial function in patients with atherosclerosis.
    Liu B, Cao HM, Li GY, Liu M, Feng J, Li J, Wang Q.
    J Int Med Res; 2011 May 15; 39(6):2314-22. PubMed ID: 22289549
    [Abstract] [Full Text] [Related]

  • 18. Effect of two intensive statin regimens on progression of coronary disease.
    Nicholls SJ, Ballantyne CM, Barter PJ, Chapman MJ, Erbel RM, Libby P, Raichlen JS, Uno K, Borgman M, Wolski K, Nissen SE.
    N Engl J Med; 2011 Dec 01; 365(22):2078-87. PubMed ID: 22085316
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of ezetimibe added to atorvastatin versus atorvastatin uptitration or switching to rosuvastatin in patients with primary hypercholesterolemia.
    Bays HE, Averna M, Majul C, Muller-Wieland D, De Pellegrin A, Giezek H, Lee R, Lowe RS, Brudi P, Triscari J, Farnier M.
    Am J Cardiol; 2013 Dec 15; 112(12):1885-95. PubMed ID: 24063830
    [Abstract] [Full Text] [Related]

  • 20. Prevention of liver cirrhosis in rats by curcumin.
    Bruck R, Ashkenazi M, Weiss S, Goldiner I, Shapiro H, Aeed H, Genina O, Helpern Z, Pines M.
    Liver Int; 2007 Apr 15; 27(3):373-83. PubMed ID: 17355460
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.